Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
4015 results
Interventional
Not Applicable
50
Isometric handgrip exercise training
Sham Training
Emory University
Source: clinicaltrials.gov
Observational
25
Western Cancer Institute
Phase3
129
bevacizumab
Biopsy Procedure
Biospecimen Collection
Computed Tomography
Fluorouracil
Irinotecan Hydrochloride
Leucovorin calcium
Magnetic Resonance Imaging
Mitomycin
Administration Questionnaire
City of Hope Medical Center
92
Pharmacist-led Medication Management Intervention
Duke University
400
Weight loss intervention
No Weight loss intervention
National Institute of Environmental Health Sciences (NIEHS)
Phase1
64
Empagliflozin 25 MG plus Pioglitazone placebo
Pioglitazone 15 mg increased to 30 mg after 2 weeks plus Empagliflozin Placebo
Empagliflozin 25 mg/d plus Pioglitazone (15/30 mg/d)
Pioglitazone placebo + Empagliflozin placebo
The University of Texas Health Science Center at San Antonio
60
ePSMI
University of Miami
Phase4
40
Atezolizumab
Y^90 Radioembolization
Icahn School of Medicine at Mount Sinai
high-power laser
Pulsed electromagnetic field
physiotherapy program
Cairo University
Kate Farms Peptide 1.5
Crohn's disease exclusion diet
James Lewis